|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―May―09 |
Association between ABO blood groups and risk of COVID-19 infection: An umbrella review |
Dorra Parv, Allahyar Shahnavazi |
2 |
[GO] |
2024―Feb―07 |
Nobel Prize in physiology or medicine 2023: Development of mRNA therapeutics that paved the path of formulation of COVID-19 vaccine |
N. C. Mandal |
3 |
[GO] |
2022―Apr―08 |
Learning hematology while surfing the waves of the COVID-19 pandemic |
Prantar Chakrabarti |
4 |
[GO] |
2022―Apr―04 |
Changes in hematological and other laboratory parameters in COVID-19 infection |
Prakas Kumar Mandal, Rishu Vidhatri |
5 |
[GO] |
2021―Nov―11 |
Optimization in understanding, management and prevention of coronavirus disease 2019 infection in hematological disorder |
Sudipta Chakrabarti |
6 |
[GO] |
2021―Sep―20 |
Vaccination for the novel coronavirus disease in hematological disorders |
Tuphan Kanti Dolai, Ankita Sen |
7 |
[GO] |
2021―Aug―30 |
Telemedicine in hematology; long-term implications of a short-term experience during COVID-19 pandemic |
Prakas Kumar Mandal, Prakash Singh Shekhawat |
8 |
[GO] |
2021―Aug―14 |
Coagulation changes in COVID-19 infection and its implication in management |
Kanjaksha Ghosh |
9 |
[GO] |
2021―Jun―03 |
Coronavirus-2019: Origin and evolution |
Nitai Chandra Mandal |